Predix Pharmaceuticals, which has facilities in Lexington, Massachusetts, and Israel, has filed to go public. The company raised $43 million in its third round of venture capital last January. Researchers at Predix are investigating compounds for general anxiety disorder, hypertension and Alzheimer's.
- read this report from Globes for more